Kramer Kelly A. bought GILD
April 30, 2026 · Form 4 insider transaction
Kramer Kelly A. bought 1,146 shares of Gilead Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,146
Price
$0.00
Total value
N/A
InsiderKramer Kelly A.
RoleDirector
CompanyGilead Sciences, Inc. (GILD)
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateApril 30, 2026
Filing dateMay 4, 2026
Shares owned after20,256
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.; 100% of the restricted stock units vested immediately upon the grant date of April 30, 2026.